Does LUMATEPERONE Cause Therapeutic response shortened? 13 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Therapeutic response shortened have been filed in association with LUMATEPERONE (CAPLYTA). This represents 0.3% of all adverse event reports for LUMATEPERONE.
13
Reports of Therapeutic response shortened with LUMATEPERONE
0.3%
of all LUMATEPERONE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapeutic response shortened From LUMATEPERONE?
Of the 13 reports.
Is Therapeutic response shortened Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUMATEPERONE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does LUMATEPERONE Cause?
Dizziness (558)
Nausea (401)
Headache (358)
Somnolence (304)
Off label use (280)
Drug ineffective (241)
Mania (211)
Sedation (208)
Feeling abnormal (206)
Anxiety (183)
What Other Drugs Cause Therapeutic response shortened?
DUPILUMAB (6,720)
ADALIMUMAB (2,597)
INFLIXIMAB-DYYB (1,837)
INFLIXIMAB (1,231)
SECUKINUMAB (1,097)
RISANKIZUMAB-RZAA (1,089)
CARBIDOPA\LEVODOPA (1,027)
ONABOTULINUMTOXINA (907)
ERENUMAB-AOOE (805)
CERTOLIZUMAB PEGOL (687)
Which LUMATEPERONE Alternatives Have Lower Therapeutic response shortened Risk?
LUMATEPERONE vs LUMIGAN
LUMATEPERONE vs LUPRON DEPOT
LUMATEPERONE vs LUPRON DEPOT-PED
LUMATEPERONE vs LURASIDONE
LUMATEPERONE vs LURBINECTEDIN